LGC SeraCare AccuSet SARS-CoV-2 Performance Panel

LGC SeraCare has released the AccuSet SARS-CoV-2 Performance Panel, an eleven-member validation panel of undiluted, naturally occurring human plasma samples. Ten panel samples represent collections from multiple individuals positive for antibodies to SARS-CoV-2; a single negative sample is also included, according to the company's website. The panel is designed to support validation studies for SARS-CoV-2 diagnostic developers and to help meet assay verification requirements in clinical laboratories.